» Articles » PMID: 22876179

Small Protease Sensitive Oligomers of PrPSc in Distinct Human Prions Determine Conversion Rate of PrP(C)

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2012 Aug 10
PMID 22876179
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

The mammalian prions replicate by converting cellular prion protein (PrP(C)) into pathogenic conformational isoform (PrP(Sc)). Variations in prions, which cause different disease phenotypes, are referred to as strains. The mechanism of high-fidelity replication of prion strains in the absence of nucleic acid remains unsolved. We investigated the impact of different conformational characteristics of PrP(Sc) on conversion of PrP(C) in vitro using PrP(Sc) seeds from the most frequent human prion disease worldwide, the Creutzfeldt-Jakob disease (sCJD). The conversion potency of a broad spectrum of distinct sCJD prions was governed by the level, conformation, and stability of small oligomers of the protease-sensitive (s) PrP(Sc). The smallest most potent prions present in sCJD brains were composed only of∼20 monomers of PrP(Sc). The tight correlation between conversion potency of small oligomers of human sPrP(Sc) observed in vitro and duration of the disease suggests that sPrP(Sc) conformers are an important determinant of prion strain characteristics that control the progression rate of the disease.

Citing Articles

"Prion-like" seeding and propagation of oligomeric protein assemblies in neurodegenerative disorders.

Zampar S, Di Gregorio S, Grimmer G, Watts J, Ingelsson M Front Neurosci. 2024; 18:1436262.

PMID: 39161653 PMC: 11330897. DOI: 10.3389/fnins.2024.1436262.


Neuropathologically directed profiling of PRNP somatic and germline variants in sporadic human prion disease.

McDonough G, Cheng Y, Morillo K, Doan R, Zhou Z, Kenny C Acta Neuropathol. 2024; 148(1):10.

PMID: 39048735 PMC: 11328154. DOI: 10.1007/s00401-024-02774-2.


Neuropathologically-directed profiling of somatic and germline variants in sporadic human prion disease.

McDonough G, Cheng Y, Morillo K, Doan R, Kenny C, Foutz A bioRxiv. 2024; .

PMID: 38979287 PMC: 11230391. DOI: 10.1101/2024.06.25.600668.


Propagation of PrP in mice reveals impact of aggregate composition on prion disease pathogenesis.

Chang S, Hannaoui S, Arifin M, Huang Y, Tang X, Wille H Commun Biol. 2023; 6(1):1162.

PMID: 37964018 PMC: 10645910. DOI: 10.1038/s42003-023-05541-3.


Evolving prion-like tau conformers differentially alter postsynaptic proteins in neurons inoculated with distinct isolates of Alzheimer's disease tau.

Hromadkova L, Kim C, Haldiman T, Peng L, Zhu X, Cohen M Cell Biosci. 2023; 13(1):174.

PMID: 37723591 PMC: 10507869. DOI: 10.1186/s13578-023-01133-0.


References
1.
Safar J, Geschwind M, Deering C, Didorenko S, Sattavat M, Sanchez H . Diagnosis of human prion disease. Proc Natl Acad Sci U S A. 2005; 102(9):3501-6. PMC: 552933. DOI: 10.1073/pnas.0409651102. View

2.
Legname G, Nguyen H, Peretz D, Cohen F, DeArmond S, Prusiner S . Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci U S A. 2006; 103(50):19105-10. PMC: 1748184. DOI: 10.1073/pnas.0608970103. View

3.
Wilham J, Orru C, Bessen R, Atarashi R, Sano K, Race B . Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog. 2010; 6(12):e1001217. PMC: 2996325. DOI: 10.1371/journal.ppat.1001217. View

4.
Klingeborn M, Race B, Meade-White K, Chesebro B . Lower specific infectivity of protease-resistant prion protein generated in cell-free reactions. Proc Natl Acad Sci U S A. 2011; 108(48):E1244-53. PMC: 3228482. DOI: 10.1073/pnas.1111255108. View

5.
Kong Q, Huang S, Zou W, Vanegas D, Wang M, Wu D . Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J Neurosci. 2005; 25(35):7944-9. PMC: 6725448. DOI: 10.1523/JNEUROSCI.2467-05.2005. View